- Home
- OPTN vs GLU Comparison
OPTN vs GLU Comparison
Compare OPTN & GLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTN
- GLU
- Stock Information
- Founded
- OPTN 2010
- GLU 2004
- Country
- OPTN United States
- GLU United States
- Employees
- OPTN N/A
- GLU N/A
- Industry
- OPTN Biotechnology: Pharmaceutical Preparations
- GLU Finance/Investors Services
- Sector
- OPTN Health Care
- GLU Finance
- Exchange
- OPTN Nasdaq
- GLU Nasdaq
- Market Cap
- OPTN 117.6M
- GLU 98.2M
- IPO Year
- OPTN 2017
- GLU N/A
- Fundamental
- Price
- OPTN $0.71
- GLU $16.19
- Analyst Decision
- OPTN Strong Buy
- GLU
- Analyst Count
- OPTN 2
- GLU 0
- Target Price
- OPTN $4.00
- GLU N/A
- AVG Volume (30 Days)
- OPTN 516.5K
- GLU 12.4K
- Earning Date
- OPTN 11-07-2024
- GLU 01-01-0001
- Dividend Yield
- OPTN N/A
- GLU 8.60%
- EPS Growth
- OPTN N/A
- GLU N/A
- EPS
- OPTN N/A
- GLU 0.62
- Revenue
- OPTN $75,058,000.00
- GLU N/A
- Revenue This Year
- OPTN $24.44
- GLU N/A
- Revenue Next Year
- OPTN $49.00
- GLU N/A
- P/E Ratio
- OPTN N/A
- GLU $22.50
- Revenue Growth
- OPTN 3.91
- GLU N/A
- 52 Week Low
- OPTN $0.65
- GLU $11.61
- 52 Week High
- OPTN $2.10
- GLU $15.40
- Technical
- Relative Strength Index (RSI)
- OPTN 33.40
- GLU 59.88
- Support Level
- OPTN $0.65
- GLU $16.10
- Resistance Level
- OPTN $0.70
- GLU $16.67
- Average True Range (ATR)
- OPTN 0.05
- GLU 0.38
- MACD
- OPTN -0.00
- GLU -0.04
- Stochastic Oscillator
- OPTN 24.67
- GLU 38.14
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.
About GLU Gabelli Global Utility of Beneficial Ownership
Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.